[
  {
    "ts": "2025-07-18T11:02:00+00:00",
    "headline": "Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments",
    "summary": "The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and microwave, the market benefits from precision treatments aligned with the rise of personalized medicine. Key players include AngioDynamics and Stryker.Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The \"Tumor Ablation Market (By Technology, Treatment Mode, Application, End-User, Regional Analysis), Company Pro",
    "url": "https://finance.yahoo.com/news/tumor-ablation-market-research-report-110200634.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "178e6a4b-ee3e-3de3-bd33-c3855939c5a8",
      "content": {
        "id": "178e6a4b-ee3e-3de3-bd33-c3855939c5a8",
        "contentType": "STORY",
        "title": "Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments",
        "description": "",
        "summary": "The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and microwave, the market benefits from precision treatments aligned with the rise of personalized medicine. Key players include AngioDynamics and Stryker.Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The \"Tumor Ablation Market (By Technology, Treatment Mode, Application, End-User, Regional Analysis), Company Pro",
        "pubDate": "2025-07-18T11:02:00Z",
        "displayTime": "2025-07-18T11:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tumor-ablation-market-research-report-110200634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tumor-ablation-market-research-report-110200634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ANGO"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]